vs
Side-by-side financial comparison of Madison Square Garden Entertainment Corp. (MSGE) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($761.7M vs $424.8M, roughly 1.8× Madison Square Garden Entertainment Corp.). Madison Square Garden Entertainment Corp. runs the higher net margin — 21.8% vs 12.0%, a 9.9% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (33.9% vs 12.5%). Over the past eight quarters, Madison Square Garden Entertainment Corp.'s revenue compounded faster (48.9% CAGR vs 24.9%).
Madison Square Garden Sports Corp. is an American sports holding company based in New York City.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
MSGE vs PODD — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $424.8M | $761.7M |
| Net Profit | $92.7M | $91.1M |
| Gross Margin | — | 69.5% |
| Operating Margin | 38.6% | 16.0% |
| Net Margin | 21.8% | 12.0% |
| Revenue YoY | 12.5% | 33.9% |
| Net Profit YoY | 22.2% | 157.3% |
| EPS (diluted) | $1.94 | $1.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $761.7M | ||
| Q4 25 | $424.8M | $783.7M | ||
| Q3 25 | $154.1M | $706.3M | ||
| Q2 25 | $145.1M | $649.1M | ||
| Q1 25 | $206.0M | $569.0M | ||
| Q4 24 | $377.6M | $597.5M | ||
| Q3 24 | $134.1M | $543.9M | ||
| Q2 24 | $177.6M | $488.5M |
| Q1 26 | — | $91.1M | ||
| Q4 25 | $92.7M | $101.6M | ||
| Q3 25 | $-21.7M | $87.6M | ||
| Q2 25 | $-27.2M | $22.5M | ||
| Q1 25 | $8.0M | $35.4M | ||
| Q4 24 | $75.9M | $100.7M | ||
| Q3 24 | $-19.3M | $77.5M | ||
| Q2 24 | $66.9M | $188.6M |
| Q1 26 | — | 69.5% | ||
| Q4 25 | — | 72.6% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 69.7% | ||
| Q1 25 | — | 71.9% | ||
| Q4 24 | — | 72.1% | ||
| Q3 24 | — | 69.3% | ||
| Q2 24 | — | 67.7% |
| Q1 26 | — | 16.0% | ||
| Q4 25 | 38.6% | 18.7% | ||
| Q3 25 | -19.3% | 16.7% | ||
| Q2 25 | -17.7% | 18.7% | ||
| Q1 25 | 13.3% | 15.6% | ||
| Q4 24 | 36.8% | 18.3% | ||
| Q3 24 | -13.8% | 16.2% | ||
| Q2 24 | -5.0% | 11.2% |
| Q1 26 | — | 12.0% | ||
| Q4 25 | 21.8% | 13.0% | ||
| Q3 25 | -14.0% | 12.4% | ||
| Q2 25 | -18.7% | 3.5% | ||
| Q1 25 | 3.9% | 6.2% | ||
| Q4 24 | 20.1% | 16.9% | ||
| Q3 24 | -14.4% | 14.2% | ||
| Q2 24 | 37.7% | 38.6% |
| Q1 26 | — | $1.30 | ||
| Q4 25 | $1.94 | $1.42 | ||
| Q3 25 | $-0.46 | $1.24 | ||
| Q2 25 | $-0.56 | $0.32 | ||
| Q1 25 | $0.17 | $0.50 | ||
| Q4 24 | $1.56 | $1.38 | ||
| Q3 24 | $-0.40 | $1.08 | ||
| Q2 24 | $1.32 | $2.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $157.1M | $480.4M |
| Total DebtLower is stronger | $554.6M | $18.6M |
| Stockholders' EquityBook value | $36.0M | $1.3B |
| Total Assets | $1.8B | $3.0B |
| Debt / EquityLower = less leverage | 15.40× | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $480.4M | ||
| Q4 25 | $157.1M | — | ||
| Q3 25 | $29.9M | — | ||
| Q2 25 | $43.0M | — | ||
| Q1 25 | $89.0M | — | ||
| Q4 24 | $54.9M | — | ||
| Q3 24 | $37.3M | — | ||
| Q2 24 | $33.3M | — |
| Q1 26 | — | $18.6M | ||
| Q4 25 | $554.6M | $930.8M | ||
| Q3 25 | $581.7M | $934.9M | ||
| Q2 25 | $568.8M | $939.0M | ||
| Q1 25 | $577.4M | $1.6B | ||
| Q4 24 | $584.7M | $1.3B | ||
| Q3 24 | $647.0M | $1.4B | ||
| Q2 24 | $599.2M | $1.4B |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $36.0M | $1.5B | ||
| Q3 25 | $-65.8M | $1.4B | ||
| Q2 25 | $-13.3M | $1.5B | ||
| Q1 25 | $9.5M | $1.3B | ||
| Q4 24 | $10.3M | $1.2B | ||
| Q3 24 | $-48.7M | $1.1B | ||
| Q2 24 | $-23.2M | $998.4M |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $1.8B | $3.2B | ||
| Q3 25 | $1.7B | $3.0B | ||
| Q2 25 | $1.7B | $3.5B | ||
| Q1 25 | $1.7B | $3.5B | ||
| Q4 24 | $1.6B | $3.1B | ||
| Q3 24 | $1.6B | $3.0B | ||
| Q2 24 | $1.6B | $2.9B |
| Q1 26 | — | 0.01× | ||
| Q4 25 | 15.40× | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | 60.61× | 1.21× | ||
| Q4 24 | 56.61× | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $164.4M | $113.8M |
| Free Cash FlowOCF − Capex | — | $89.5M |
| FCF MarginFCF / Revenue | — | 11.8% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | 1.77× | 1.25× |
| TTM Free Cash FlowTrailing 4 quarters | — | $415.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $113.8M | ||
| Q4 25 | $164.4M | $183.3M | ||
| Q3 25 | $19.8M | $125.7M | ||
| Q2 25 | $-27.0M | $196.5M | ||
| Q1 25 | $56.8M | $63.8M | ||
| Q4 24 | $112.9M | $147.7M | ||
| Q3 24 | $-27.4M | $98.5M | ||
| Q2 24 | $212.0K | $96.5M |
| Q1 26 | — | $89.5M | ||
| Q4 25 | — | $48.2M | ||
| Q3 25 | — | $100.1M | ||
| Q2 25 | — | $177.9M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $94.1M | ||
| Q3 24 | — | $71.8M | ||
| Q2 24 | — | $74.0M |
| Q1 26 | — | 11.8% | ||
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | — | 27.4% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | — | 15.7% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 15.1% |
| Q1 26 | — | 3.2% | ||
| Q4 25 | — | 17.2% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 9.0% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 4.6% |
| Q1 26 | — | 1.25× | ||
| Q4 25 | 1.77× | 1.80× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 8.73× | ||
| Q1 25 | 7.07× | 1.80× | ||
| Q4 24 | 1.49× | 1.47× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | 0.00× | 0.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MSGE
| Ticketing And Venue License Fee Revenues | $263.5M | 62% |
| Food Beverage And Merchandise Revenues | $64.3M | 15% |
| Related Party | $43.9M | 10% |
| Arena Licensing Fees And Other Leasing Revenue | $35.2M | 8% |
| Other | $15.9M | 4% |
PODD
| Omnipod | $515.6M | 68% |
| International Omnipod | $242.9M | 32% |
| Drug Delivery | $3.3M | 0% |
